Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin.

Lane RS, Femel J, Breazeale AP, Loo CP, Thibault G, Kaempf A, Mori M, Tsujikawa T, Chang YH, Lund AW.

J Exp Med. 2018 Oct 31. pii: jem.20180654. doi: 10.1084/jem.20180654. [Epub ahead of print]

PMID:
30381467
2.

Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection.

Loo CP, Nelson NA, Lane RS, Booth JL, Loprinzi Hardin SC, Thomas A, Slifka MK, Nolz JC, Lund AW.

Cell Rep. 2017 Sep 26;20(13):3176-3187. doi: 10.1016/j.celrep.2017.09.006.

4.

NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection.

Kuylenstierna C, Snyder-Cappione JE, Loo CP, Long BR, Gonzalez VD, Michaëlsson J, Moll M, Spotts G, Hecht FM, Nixon DF, Sandberg JK.

Scand J Immunol. 2011 Feb;73(2):141-6. doi: 10.1111/j.1365-3083.2010.02484.x.

5.

Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.

Ndhlovu LC, Snyder-Cappione JE, Carvalho KI, Leal FE, Loo CP, Bruno FR, Jha AR, Devita D, Hasenkrug AM, Barbosa HM, Segurado AC, Nixon DF, Murphy EL, Kallas EG.

Clin Exp Immunol. 2009 Dec;158(3):294-9. doi: 10.1111/j.1365-2249.2009.04019.x. Epub 2009 Sep 2.

6.

Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.

Snyder-Cappione JE, Loo CP, Carvalho KI, Kuylenstierna C, Deeks SG, Hecht FM, Rosenberg MG, Sandberg JK, Kallas EG, Nixon DF.

AIDS. 2009 Sep 24;23(15):1965-70. doi: 10.1097/QAD.0b013e32832b5134.

PMID:
19590406
7.

HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.

Loo CP, Long BR, Hecht FM, Nixon DF, Michaëlsson J.

AIDS Res Hum Retroviruses. 2009 Jun;25(6):603-5. doi: 10.1089/aid.2009.0165.

8.

Metastatic nasal chondrosarcoma.

Sathappan S, Razak HA, Loo CP.

Med J Malaysia. 2007 Oct;62(4):347-8.

9.

Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.

Michaëlsson J, Long BR, Loo CP, Lanier LL, Spotts G, Hecht FM, Nixon DF.

J Infect Dis. 2008 Jan 1;197(1):117-25. doi: 10.1086/524141.

10.

Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus.

Long BR, Michaelsson J, Loo CP, Ballan WM, Vu BA, Hecht FM, Lanier LL, Chapman JM, Nixon DF.

Clin Vaccine Immunol. 2008 Jan;15(1):120-30. Epub 2007 Nov 14.

11.

FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.

Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM.

J Leukoc Biol. 2008 Feb;83(2):254-62. Epub 2007 Nov 2.

PMID:
17982112
12.

Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.

Ballan WM, Vu BA, Long BR, Loo CP, Michaëlsson J, Barbour JD, Lanier LL, Wiznia AA, Abadi J, Fennelly GJ, Rosenberg MG, Nixon DF.

J Immunol. 2007 Sep 1;179(5):3362-70.

13.

Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells.

Snyder-Cappione JE, Nixon DF, Loo CP, Chapman JM, Meiklejohn DA, Melo FF, Costa PR, Sandberg JK, Rodrigues DS, Kallas EG.

J Infect Dis. 2007 May 1;195(9):1361-4. Epub 2007 Mar 20.

PMID:
17397008
14.

Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.

Northfield JW, Loo CP, Barbour JD, Spotts G, Hecht FM, Klenerman P, Nixon DF, Michaëlsson J.

J Virol. 2007 Jun;81(11):5759-65. Epub 2007 Mar 21.

15.

Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.

Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, Diaz RS, Santos AM, Succi RC, Abadi J, Rosenberg MG, de Moraes-Pinto MI, Kallas EG.

PLoS One. 2006 Dec 20;1:e102.

16.

Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases.

Amagata T, Whitman S, Johnson TA, Stessman CC, Loo CP, Lobkovsky E, Clardy J, Crews P, Holman TR.

J Nat Prod. 2003 Feb;66(2):230-5.

PMID:
12608855

Supplemental Content

Support Center